Welcome to the world of Influenza
>
News & Publications
>
Solvay’s cell-based production facility for Influenza vaccines validated and operational
Other Solvay Sites
------------------------------------------------
Solvay.com
---------- Business Portals ----------
PHARMACEUTICALS PORTAL
Aceon
Androgel
Depression Center
Duodopa
Duphalac
Duphalac Italy
Influenza Center
Irritable Bowel Syndrome
Lactulose
Marinol
Menopause Center
Moses Study
Solvay Arzneimmittel
Solvay Healthcare
Solvay Injectables
Solvay Omacor
Solvay Pharma Belgium
Solvay Pharma Canada
Solvay Pharma Espana
Solvay Pharma Schweiz
Solvay Pharmaceuticals - AMAC
Solvay Pharmaceuticals NL
Solvay Pharmaceuticals US
Teveten
CHEMICALS PORTAL
PLASTICS PORTAL
> Other sites by Businesses
----------- Country Portals -----------
Solvay Austria
Solvay China
Solvay Seiyaku
Solvay Deutschland
Solvay France
Solvay Iberica
Solvay Italia
Solvay Nordic
Solvay North America
Solvay Portugal
Solvay Schweiz
> Other sites by Regions
Ce Site
Tous
SOLVAY.COM
SOLVAY INFLUENZA
About Influenza
About Influenza
How important is Influenza ?
Complications of Influenza
Influenza in healthy adults and children
Are you at risk?
Cost of Influenza
Influenza FAQ's
About Influenza Vaccination
About Vaccination
Who should get vaccinated?
When and how?
Clinical benefits of influenza vaccination
Economical benefits of influenza vaccination
Adverse reactions to influenza vaccine?
Vaccination FAQ's
News & Publications
News and Press
Books
Congresses
Flu vaccination calculator
Vaccine composition
Influenza links
Contact - more info
World Map
Solvay Pharmaceuticals
version:
[EN]
-
[NL]
-
> 09 septembre, 2009<
L’usine de solvay pour la production de vaccins antigrippaux par culture cellulaire est validee et operationnelle
|
Envoyer par email
|
© Solvay S.A • Informations importantes :
Privacy Policy
-
Disclaimer
• Pour tout commentaire, veuillez contacter le
webmaster
Date de dernière mise à jour: 6/7/2010
